Nuversys
PrivateLast Round
Series A
Mar 17, 2024
Est. Valuation
$9.5M
Total Funding Raised
$5.7M
Company Overview
Nuversys operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Series A round in March 2024.
Nuversys is a food-tech company that offers patented, nutrient-dense food ingredients based on a proprietary microencapsulation technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuversys Comparables
Compare Nuversys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TasteTech | 75% | |
| ADAMA Ltd. | 69% | |
| Balchem Corporation | 68% |
For institutional investors. Book with your work email.
Nuversys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 17, 2024 | ||||
| Convertible Debt | Sep 10, 2023 | ||||
| Seed | Dec 13, 2022 | ||||
| Seed | Jan 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nuversys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FEAT Investments | Series A, Convertible Debt, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2024
Grew 43% QoQ, from 7 to 10 employees.
- Mar 17, 2024
$1.5M round led by FEAT Investments
For institutional investors. Book with your work email.
Nuversys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nuversys's valuation, stock price, and market status.
Is Nuversys a public or private company?
Nuversys is a private company.
What is the current stock price of Nuversys?
Nuversys is a private company, so its shares have no public market price. Caplight tracks Nuversys's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuversys worth (valuation)?
Nuversys's valuation is estimated at $9.5M based on funding round data.
Can I buy Nuversys stock?
Nuversys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuversys's last funding round?
Nuversys's most recent funding round was Series A on March 17, 2024.
Who are the main investors in Nuversys?
Key investors in Nuversys include FEAT Investments.
Will Nuversys IPO soon?
No public IPO plans have been announced for Nuversys.
How can I track Nuversys secondary market activity?
Caplight tracks bids, offers, and trades in Nuversys's shares on secondary markets.